Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2016
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 16 Mar 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 15 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 according to ClinicalTrials.gov record.
- 28 Feb 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.